| 書目名稱 | Drug Discovery | | 副標題 | A Casebook and Analy | | 編輯 | Robert A. Maxwell,Shohreh B. Eckhardt | | 視頻video | http://file.papertrans.cn/284/283065/283065.mp4 | | 圖書封面 |  | | 描述 | This treatise had its origins in the authors‘ strong opinion that the discovery of new drugs, especially of innovative therapeutic agents, really does not happen as a spontaneous sequel to investiga- tive research, no matter how penetrating such research may be. Rather, it seemed to us that the discovery of innovative therapeutic agents was a very active process, existing in and of itself, and demanding full attention-it was not simply a passive, dependent by-process of investigative research. And yet, many researchers- some close confreres of the authors, others more distant-believed otherwise. We felt that their view reflected unrealistic thinking and that reality probably lay closer to what Beyer" maintained: We are taught to believe that if we can understand a disease it should be easy enough to figure out, say, the molecular configuration of a definitive receptor mechanism somewhere along the line and to design a specific drug . . . . And so we start out to understand the disease but never get around to doing much about therapy. The authors very soon realized that there was essentially no quantitive information available on just where and how innovative therapeutic agents were | | 出版日期 | Book 1990 | | 關鍵詞 | calcium; clinical research; drug; drug discovery; research; transplantation | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-4612-0469-5 | | isbn_softcover | 978-1-4612-6775-1 | | isbn_ebook | 978-1-4612-0469-5 | | copyright | Springer Science+Business Media New York 1990 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網安備110108008328)
GMT+8, 2025-10-7 20:55
發(fā)表于 2025-3-21 17:34:09
